All News

Teaching Children — and the World — to Use Breathing Techniques for Cancer-Related Pain

February 2nd 2023

In this episode of the “Cancer Horizons” podcast, “Rabbi G” discusses his global travels to teach breathwork to children with cancer, and gives an exercise listeners can use to decrease their pain and anxiety.

How Cancer Saved Me

February 2nd 2023

While cancer is a horrible disease, it taught me some valuable lessons.

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

February 1st 2023

The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.

Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs

February 1st 2023

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients

February 1st 2023

Older patients with advanced cancer who were taking eight or more medications before starting treatment were more likely to discontinue treatment and/or experience a side effect from drug interactions.

CAR-T Cell Therapy May Confer Responses in Relapsed/Refractory CLL or SLL, Preliminary Data Shows

February 1st 2023

The TRANSCNED CLL 004 trial met its primary endpoint of complete responses with the CAR-T cell therapy Breyanzi in patients with relapsed or refractory CLL or SLL.

Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how cancer care has changed over the years.

Oncologists Have Feelings Too: Navigating the Patient Physician Relationship

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how patients can better understand the emotions their oncologists may be going through during treatment.

Debunking Myths of Clinical Trials for Cancer

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about clinical trials in cancer care.

Highlighting Geographic, Economic Disparities in Cancer Care

January 31st 2023

Jumping Through Insurance Hoops for Treatment

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about the challenges patients and physicians face with insurance matters during cancer care.

Immunotherapy Combination ‘Huge Benefit’ for Some Patients With Colorectal Cancer

January 31st 2023

Patients with refractory metastatic colorectal cancer often don’t have many effective treatment options, although immunotherapy may be a promising potential for patients based on recent study findings.

Cancer Made Me Superstitious

January 31st 2023

After being diagnosed with cancer, I’m nervous to plan for my future, and can’t say I’m in remission without knocking on wood.

Prostate Cancer Symptoms Can Be Managed Years After Treatment

January 31st 2023

An expert on urological side effects of cancer treatments most often associated with prostate cancer discusses options, even for those decades past initial treatment.

Trial to Investigate If Novel Drug Combo Can Boost Outcomes in Lung Cancer

January 31st 2023

A phase 3 trial will test datopotamab deruxtecan in combination with Keytruda with or without chemotherapy for certain patients with metastatic non-small cell lung cancer.

Understanding Robotic Surgery in Cervical Cancer

January 30th 2023

Efficacy with robotic surgery in early-stage cervical cancer is currently being studied, to hopefully offer patients an option with better recovery compared to open surgery.

Brukinsa Offers Better Response and Less Toxicity for CLL and SLL Treatment, But a Cure Is Still Needed

January 30th 2023

Two experts explain what patients need to know about the recent approval of Brukinsa for patients with chronic lymphocytic leukemia and small lymphocytic leukemia.

My Dog’s Love Gave Me the Will to Live During Cancer

January 30th 2023

After being diagnosed with leukemia, my Golden Retriever, Payton, was my emotional caregiver and gave me the will to live.

On Cancer and Careers: How a Diagnosis Changed Survivors’ Jobs

January 30th 2023

We asked our audience of cancer survivors how their diagnosis affected their careers. Here’s what they had to say.

Ongoing Trial Shows Positive Response Rates With MEK Inhibitor Combo in Ovarian Cancer Subset

January 30th 2023

Women with low-grade serous ovarian cancer treated with avutometinib and defactinib experienced positive response rates compared with avutometinib alone.

Adjuvant Chemoradiotherapy Demonstrated Better Outcomes for Patients With Endometrial Cancer

January 29th 2023

Chemoradiotherapy may be an appropriate treatment option after surgery for patients with stage 3 endometrial cancer, especially those are a higher risk of recurrence.

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28th 2023

I was shocked when I was diagnosed with a myeloproliferative neoplasm, and have dedicated myself to learning about the disease since.

First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer

January 28th 2023

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.

FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer

January 27th 2023

The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma

January 27th 2023

The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.

The Day I Realized My Oncologist Was a Real Person

January 27th 2023

I always viewed my doctors as being unapproachable on a personal level. I thought they were there to examine and diagnose me, imparting wisdom I could never hope to attain, but one day I realized I was very wrong.

Michael Bublé Discusses His Son’s Cancer, TikTok Star Dies of CRC and More

January 27th 2023

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

Trial to Investigate Novel Drug in KRAS-Mutant Lung Cancer

January 27th 2023

VIC-1911 will be studied alone or with Lumakras in patients with KRAS G12C-mutant non-small cell lung cancer.

FDA Approves Post-Surgical Keytruda for Lung Cancer Subset

January 26th 2023

The Food and Drug Administration approved Keytruda, an immunotherapy agent, for patients with stage 1B, 2 or 3A non-small cell lung cancer.